Astrazeneca (AZN) Change in Intangibles (2009 - 2026)

Astrazeneca has reported Change in Intangibles for 14 years, with the latest figure at $120.0 million in Q2 2026.

• On a quarterly basis, Change in Intangibles rose 39.53% year-over-year to $120.0 million in Q2 2026; TTM through Jun 2026 was $206.0 million, a 44.06% increase from a year earlier, with the FY2025 full-year figure at $136.0 million, up 10.57% from the prior year.
• Change in Intangibles was $120.0 million for Q2 2026 at Astrazeneca, up from $45.0 million in the prior quarter.
• The five-year high for Change in Intangibles was $385.0 million in Q1 2022, with the low at $1.0 million in Q3 2025.
• Average Change in Intangibles over 5 years is $88.8 million, with a median of $45.0 million recorded in 2026.
• The sharpest annual moves came in 2025 and 2026: Change in Intangibles plunged 96.88% in 2025, then jumped 400.0% in 2026.
• Over 5 years, Change in Intangibles stood at $57.0 million in 2022, then plunged by 57.89% to $24.0 million in 2023, then plunged by 33.33% to $16.0 million in 2024, then surged by 150.0% to $40.0 million in 2025, then jumped by 200.0% to $120.0 million in 2026.
• The last three Change in Intangibles figures came in at $120.0 million (Q2 2026), $45.0 million (Q1 2026), and $40.0 million (Q4 2025), per Business Quant data.